Core Viewpoint - The company, Huajian Medical (01931), announced a sustainable development-linked syndicated loan agreement for its subsidiary, Weishida Medical Equipment (Shanghai) Co., Ltd., which will provide a significant amount of revolving loans, reflecting strong market response and recognition from financial institutions [1] Group 1: Loan Agreement Details - The loan agreement was established on July 10, 2025, with a total amount reaching several hundred million RMB [1] - The repayment period for the loan is set at 12 months from the date of the first drawdown [1] - The syndicate is led by East Asia Bank (China) Co., Ltd. Shanghai Branch, with participation from several other banks including Sumitomo Mitsui Banking Corporation (China) Co., Ltd. and others [1] Group 2: Financial Implications - The revolving credit facility allows for repeated drawdowns during the drawdown period, providing Weishida with a flexible and ample medium to long-term funding pool [1] - The approval of this syndicated loan indicates a strong market response and highlights the recognition of Weishida's robust operations and sustainable development strategy by international and regional financial institutions [1]
华检医疗子公司威士达获得总额达数亿元人民币的循环贷款